Literature DB >> 12686860

Endoscopic treatment of primary grades IV and V vesicoureteral reflux in children with subureteral injection of polytetrafluoroethylene.

Boris Chertin1, Diane De Caluwé, Prem Puri.   

Abstract

PURPOSE: We evaluated our experience with endoscopic STING (subureteral polytetrafluoroethylene injection) for grades IV and V vesicoureteral reflux.
MATERIALS AND METHODS: We reviewed the records of 221 boys and 305 girls who underwent STING for primary grades IV (430) and V (96) vesicoureteral reflux between 1984 and 2000. Median patient age at STING was 3 years (range 3 months to 14 years). Reflux was unilateral and bilateral in 335 and 191 children, respectively (717 refluxing units). Median followup was 11.6 years (range 1 to 17).
RESULTS: Reflux was corrected in 420 of the 717 refluxing units (58%) after a single injection. Reflux resolved after a second and third injection in 185 ureters (26%). High grade reflux was converted to grades I and II in 112 ureters (15%) and did not require any further treatment. STING failed to correct reflux in 7 units (0.9%), which were managed by ureteral reimplantation (5) and nephrectomy (2) due to poor renal function. Voiding cystourethrography showed recurrent vesicoureteral reflux in 9 units (1.2%), including 2 with low grade reflux for which no treatment was given. Seven ureters required repeat injection due to grades III and IV reflux. No untoward effects were noted in any patients in whom polytetrafluoroethylene was used as the injected material.
CONCLUSIONS: STING is a simple, safe and effective outpatient procedure for grades IV and V vesicoureteral reflux.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12686860     DOI: 10.1097/01.ju.0000062300.71507.3a

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Endoscopic subureteral injection treatment with calcium hydroxylapatite in primary vesicoureteral reflux.

Authors:  Bilal Eryildirim; Fatih Tarhan; Uğur Kuyumcuoğlu; Erkan Erbay; Gökhan Faydaci
Journal:  Int Urol Nephrol       Date:  2007       Impact factor: 2.370

2.  Histological response to injected dextranomer-based implant in a rat model.

Authors:  Murat Alkan; Arbay O Ciftci; Beril Talim; Mehmet E Senocak; Melda Caglar; Nebil Buyukpamukcu
Journal:  Pediatr Surg Int       Date:  2006-10-17       Impact factor: 1.827

3.  Surgical intervention in children with vesicoureteric reflux: are we intervening too late?

Authors:  Basem A Khalil; Anju Goyal; Alan P Dickson
Journal:  Pediatr Surg Int       Date:  2010-05-29       Impact factor: 1.827

4.  Endoscopic bulking materials for the treatment of vesicoureteral reflux: a review of our 20 years of experience and review of the literature.

Authors:  Boris Chertin; Stanislav Kocherov; Leonid Chertin; Alaeddin Natsheh; Amicur Farkas; Ofer Z Shenfeld; Sarel Halachmi
Journal:  Adv Urol       Date:  2011-04-06

5.  Histological response to injected gluteraldehyde cross-linked bovine collagen based implant in a rat model.

Authors:  Murat Alkan; Beril Talim; Arbay O Ciftci; Mehmet E Senocak; Melda Caglar; Nebil Büyükpamukçu
Journal:  BMC Urol       Date:  2006-02-18       Impact factor: 2.264

6.  A review of the effect of injected dextranomer/hyaluronic Acid copolymer volume on reflux correction following endoscopic injection.

Authors:  Sumit Dave; Darius J Bägli
Journal:  Adv Urol       Date:  2008
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.